Article ; Online: Non-invasive, Real-time, Glucose Monitoring is in the Near Future.
Diabetes technology & therapeutics
2024
Abstract: Objective: Since the introduction of continuous glucose monitoring technology, developers have rigorously researched the feasibility of creating a noninvasive glucose monitoring device. In a recent pilot study, investigators reported a strong ... ...
Abstract | Objective: Since the introduction of continuous glucose monitoring technology, developers have rigorously researched the feasibility of creating a noninvasive glucose monitoring device. In a recent pilot study, investigators reported a strong correlation between glucose values obtained from novel, noninvasive monitoring device (GWave) values to venous and capillary glucose measurements. Research design and methods: We investigated if the level of accuracy observed in the pilot study could be reproduced in a larger cohort, using a smaller third-generation, manufacturable device (Gen III GWave) containing a standardized sensor chip that can be mass produced for commercial use. The evaluation assessed concordance with capillary blood glucose, reproducibility between two gen III devices, and accuracy during insulin-induced hypoglycemia. Results: Assessment of samples from 75 subjects (T2D, n=6; T1D, n=28; nondiabetic pregnant subjects, n=10; and nondiabetic, n=31) showed that 97% of values were in Zone A with 3% in Zone B of the Clarke Error Grid, with a mean absolute relative difference (MARD) of 6.7% from reference blood glucose. Comparison between two independent Gen III GWave devices demonstrated reproducibility between the sensors (R2=0.95), with 100% of values within Zone A. In the hypoglycemia assessment, measurements from the Gen III sensor tightly followed the capillary glucose measurements down to 42 mg/dL (2.3 mmol/L), whereas the CGM measurements from two different CGM only converged with the GWave and capillary glucose readings after 90 minutes of decreasing glucose levels. Conclusion: Our results show promise as potentially the first noninvasive technology. Future studies will focus on larger numbers of people in all glucose ranges. Real-time noninvasive blood glucose monitoring is possible using GWave technology. |
---|---|
Language | English |
Publishing date | 2024-02-28 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 1452816-2 |
ISSN | 1557-8593 ; 1520-9156 |
ISSN (online) | 1557-8593 |
ISSN | 1520-9156 |
DOI | 10.1089/dia.2024.0009 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5269: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.